knowledge -WSS

knowledge

author：hotspot 2025-10-02 11:10:10 - browse：579

Sarepta - Cambridge -AP — Kristoffer Tripplaar/Sipa via AP

The Food and Drug Administration granted conditional approval Thursday to the first gene therapy for Duchenne muscular dystrophy. Regulators restricted the treatment to younger patients, with additional data required to broaden its use.

The gene therapy, called Elevydis, is made by Sarepta Therapeutics. The company will charge $3.2 million for the treatment, making it the U.S.’s second most expensive drug, behind a recently approved gene therapy for hemophilia. CEO Doug Ingram said on a conference call the price was below what a recently published company-funded analysis found would be cost-effective.

“The approval of Elevidys is a watershed moment for the treatment of Duchenne. Elevydis is the first and only gene therapy approved for Duchenne, and this approval brings us closer to our goal of bringing forward a treatment that provides the potential to alter the trajectory of this degenerative disease,” Ingram said.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： BioMarin wins approval for gene therapy to treat hemophilia A
Next article： Hospitals struggle to profit from CAR

focus

hotspot

WSS

Sen. Bill Cassidy on how to lower drug prices

Zelenskyy on how Russian invasion may end, gratitude for US aid and Putin's weakness

Rare Northern Lights show in US this week: Where and how to see it

EF3 tornado rips through North Carolina amid extreme weather nationwide

Masked men burn a market in a Mexican city plagued by gang violence, killing 9 people

Driven by the pandemic, applicants flood public health schools

focus

knowledge

focus

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

I learned firsthand about improving diversity in clinical trials

Sports medicine is finally prioritizing gender equality

Affordable Connectivity Program vital to health care, experts say

Sports medicine is finally prioritizing gender equality

With fresh data, a dynamic duo powers Eli Lilly to new heights

Anesthesiologist group: stop taking Ozempic before surgery

Neutralizing antibodies against HIV shows promise in children

Medicare details structure of new drug price negotiation program

Wildfires rage amid heat wave in Greece, prompting evacuations and call for European support

Wikipedia

Ending racial health disparities hinges on penalties, political will

Driven by the pandemic, applicants flood public health schools

What are cluster munitions? Biden defends decision to send controversial weapons to Ukraine

Ending racial health disparities hinges on penalties, political will

North Korean leader's powerful sister says warplanes repelled US spy plane

Senate committee advances SCOTUS ethics bill after alleged justice misconduct

focus

leisure time

hotspot

hotspot